Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial

Research output: Journal contributionsJournal articlesResearchpeer-review

Standard

Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. / Van Bastelaar, K.M.P.; Pouwer, F.; Cuijpers, Pim et al.
In: Diabetes Care, Vol. 34, No. 2, 02.2011, p. 320-325.

Research output: Journal contributionsJournal articlesResearchpeer-review

Harvard

APA

Vancouver

Van Bastelaar KMP, Pouwer F, Cuijpers P, Riper H, Snoek FJ. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2011 Feb;34(2):320-325. doi: 10.2337/dc10-1248

Bibtex

@article{4379ae536f9240e8bf717e5b395f907f,
title = "Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial",
abstract = "OBJECTIVE: Comorbid depression is common in patients with type 1 and type 2 diabetes, adversely affecting quality of life, diabetes outcomes, and mortality. Depression can be effectively treated with cognitive behavior therapy (CBT). The Internet is a new and attractive method for delivering CBT intervention on a large scale at relatively low costs. This study evaluated the effectiveness of Web-based CBT for depression treatment in adults with type 1 or type 2 diabetes, with minimal guidance. RESEARCH DESIGN AND METHODS: A randomized controlled trial was conducted in the Netherlands in 255 adult diabetic patients with elevated depressive symptoms. Primary outcomes were depressive symptoms. Secondary outcomes were diabetes-specific emotional distress and glycemic control. Assessments were at baseline, after treatment, and at the 1-month follow-up. RESULTS: The Web-based CBT was effective in reducing depressive symptoms by intention-to-treat analyses (P = 0.04, d = 0.29; clinical improvement 41% vs. 24% P < 0.001) and by per-protocol analyses (P < 0.001, d = 0.70; clinical improvement, 56% vs. 24% P < 0.001). The intervention reduced diabetes-specific emotional distress (P = 0.03) but had no beneficial effect on glycemic control (P > 0.05). CONCLUSIONS: Web-based CBT depression treatment is effective in reducing depressive symptoms in adults with type 1 and type 2 diabetes. In addition, the intervention reduces diabetes-specific emotional distress in depressed patients.",
keywords = "Health sciences, Psychology",
author = "{Van Bastelaar}, K.M.P. and F. Pouwer and Pim Cuijpers and Heleen Riper and F.J. Snoek",
year = "2011",
month = feb,
doi = "10.2337/dc10-1248",
language = "English",
volume = "34",
pages = "320--325",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Web-based depression treatment for type 1 and type 2 diabetic patients

T2 - a randomized, controlled trial

AU - Van Bastelaar, K.M.P.

AU - Pouwer, F.

AU - Cuijpers, Pim

AU - Riper, Heleen

AU - Snoek, F.J.

PY - 2011/2

Y1 - 2011/2

N2 - OBJECTIVE: Comorbid depression is common in patients with type 1 and type 2 diabetes, adversely affecting quality of life, diabetes outcomes, and mortality. Depression can be effectively treated with cognitive behavior therapy (CBT). The Internet is a new and attractive method for delivering CBT intervention on a large scale at relatively low costs. This study evaluated the effectiveness of Web-based CBT for depression treatment in adults with type 1 or type 2 diabetes, with minimal guidance. RESEARCH DESIGN AND METHODS: A randomized controlled trial was conducted in the Netherlands in 255 adult diabetic patients with elevated depressive symptoms. Primary outcomes were depressive symptoms. Secondary outcomes were diabetes-specific emotional distress and glycemic control. Assessments were at baseline, after treatment, and at the 1-month follow-up. RESULTS: The Web-based CBT was effective in reducing depressive symptoms by intention-to-treat analyses (P = 0.04, d = 0.29; clinical improvement 41% vs. 24% P < 0.001) and by per-protocol analyses (P < 0.001, d = 0.70; clinical improvement, 56% vs. 24% P < 0.001). The intervention reduced diabetes-specific emotional distress (P = 0.03) but had no beneficial effect on glycemic control (P > 0.05). CONCLUSIONS: Web-based CBT depression treatment is effective in reducing depressive symptoms in adults with type 1 and type 2 diabetes. In addition, the intervention reduces diabetes-specific emotional distress in depressed patients.

AB - OBJECTIVE: Comorbid depression is common in patients with type 1 and type 2 diabetes, adversely affecting quality of life, diabetes outcomes, and mortality. Depression can be effectively treated with cognitive behavior therapy (CBT). The Internet is a new and attractive method for delivering CBT intervention on a large scale at relatively low costs. This study evaluated the effectiveness of Web-based CBT for depression treatment in adults with type 1 or type 2 diabetes, with minimal guidance. RESEARCH DESIGN AND METHODS: A randomized controlled trial was conducted in the Netherlands in 255 adult diabetic patients with elevated depressive symptoms. Primary outcomes were depressive symptoms. Secondary outcomes were diabetes-specific emotional distress and glycemic control. Assessments were at baseline, after treatment, and at the 1-month follow-up. RESULTS: The Web-based CBT was effective in reducing depressive symptoms by intention-to-treat analyses (P = 0.04, d = 0.29; clinical improvement 41% vs. 24% P < 0.001) and by per-protocol analyses (P < 0.001, d = 0.70; clinical improvement, 56% vs. 24% P < 0.001). The intervention reduced diabetes-specific emotional distress (P = 0.03) but had no beneficial effect on glycemic control (P > 0.05). CONCLUSIONS: Web-based CBT depression treatment is effective in reducing depressive symptoms in adults with type 1 and type 2 diabetes. In addition, the intervention reduces diabetes-specific emotional distress in depressed patients.

KW - Health sciences

KW - Psychology

UR - http://www.scopus.com/inward/record.url?scp=79951692037&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/4c2a4198-e1ac-3595-8738-155ec4cd382a/

U2 - 10.2337/dc10-1248

DO - 10.2337/dc10-1248

M3 - Journal articles

C2 - 21216855

VL - 34

SP - 320

EP - 325

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 2

ER -

Documents

DOI

Recently viewed

Researchers

  1. Kara O'Neil

Publications

  1. Zur Nährstoff- und Vegetationsdynamik von Heide-Ökosystemen
  2. Mythos und Wahrheit
  3. Collisions in Space
  4. Die große Flut und die Arche
  5. "Und blieb ein Dichter und ein Narr"
  6. Translation
  7. Einleitung
  8. Unternehmensnachfolgeprozesse in Klein- und Mikrounternehmen
  9. Spiegelbild, sprechender Spiegel, leerer Spiegel
  10. Alice in different Wonderlands
  11. Maler und Modell - eine kultivierte Beziehung
  12. Mise en scène / Jérôme Bel
  13. Programme des Lebens
  14. Hermann Bahr.
  15. Wer arbeitet wann?
  16. Transmitting Culture within Linguistic Alterity
  17. Kapitalstrukturentwicklung in der Frühentwicklungsphase von Existenzgründungen
  18. Anticipated and experienced emotions in environmental risk perception
  19. Becoming prosumer
  20. Debis career development center
  21. Die Farbbeutel-Rede Joschka Fischers
  22. Bilanz machen!
  23. Conflicts over coastal protection in a National Park: Mediation and negotiated law making
  24. The difficulty to behave as a (regulated) natural monopolist
  25. Das Wissen des Profils
  26. Nachweis der Anspruchshöhe bei gekündigtem Einheitspreisvertrag
  27. Why Abandon the Paradise?
  28. Biodiversitätsforschung im Wald
  29. Lebenszyklen touristischer Destinationen
  30. Besser informieren
  31. Institutional Entrepreneurship
  32. Von der Suderburger Wiesenbauschule zur Modelluniversität
  33. Freedom Rising
  34. §49 Windenergie an Land
  35. Körper und Geschlechtlichkeit
  36. Zwischen Erziehung und Unterhaltung
  37. Klein, Naomi (b. 1970) and the Movement Against Neoliberal Globalization
  38. La qualification des infractions fiscales en Allemagne
  39. Green chemistry and its contribution to industrial biotechnology